$128.18
5.28%
Nasdaq, Aug 22, 10:00 pm CET

ICU Medical, Inc. Stock price

$128.18
+1.94 1.54% 1M
-32.07 20.01% 6M
-26.99 17.39% YTD
-30.65 19.30% 1Y
-34.29 21.11% 3Y
-54.41 29.80% 5Y
+18.85 17.24% 10Y
+97.98 324.44% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+6.43 5.28%

Key metrics

Basic
Market capitalization
$3.2b
Enterprise Value
$4.2b
Net debt
$1.0b
Cash
$300.0m
Shares outstanding
24.7m
Valuation (TTM | estimate)
P/E
negative | 18.0
P/S
1.3 | 1.4
EV/Sales
1.8 | 1.9
EV/FCF
83.3
P/B
1.5
Financial Health
Equity Ratio
46.8%
Return on Equity
-6.0%
ROCE
3.6%
ROIC
-10.9%
Debt/Equity
0.6
Financials (TTM | estimate)
Revenue
$2.4b | $2.2b
EBITDA
$130.3m | $394.2m
EBIT
$128.9m | $294.2m
Net Income
$-37.0m | $176.0m
Free Cash Flow
$50.5m
Growth (TTM | estimate)
Revenue
3.0% | -6.1%
EBITDA
117.0% | 279.2%
EBIT
118.8% | 186.1%
Net Income
47.8% | 249.6%
Free Cash Flow
-67.8%
Margin (TTM | estimate)
Gross
35.8%
EBITDA
5.5% | 17.6%
EBIT
5.4%
Net
-1.6% | 7.9%
Free Cash Flow
2.1%
More
EPS
$-1.5
FCF per Share
$2.0
Short interest
6.1%
Employees
15k
Rev per Employee
$160.0k
Show more

Is ICU Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

ICU Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a ICU Medical, Inc. forecast:

9x Buy
82%
2x Hold
18%

Analyst Opinions

11 Analysts have issued a ICU Medical, Inc. forecast:

Buy
82%
Hold
18%

Financial data from ICU Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,373 2,373
3% 3%
100%
- Direct Costs 1,522 1,522
2% 2%
64%
850 850
14% 14%
36%
- Selling and Administrative Expenses 637 637
3% 3%
27%
- Research and Development Expense 89 89
0% 0%
4%
130 130
117% 117%
5%
- Depreciation and Amortization 1.42 1.42
26% 26%
0%
EBIT (Operating Income) EBIT 129 129
119% 119%
5%
Net Profit -37 -37
48% 48%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about ICU Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ICU Medical, Inc. Stock News

Neutral
GlobeNewsWire
4 days ago
SAN CLEMENTE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences in September:
Neutral
Seeking Alpha
15 days ago
ICU Medical, Inc. (NASDAQ:ICUI ) Q2 2025 Earnings Call August 7, 2025 4:30 PM ET Company Participants Brian Michael Bonnell - CFO & Treasurer Vivek Jain - CEO & Chairman of the Board Conference Call Participants Charles S. Strauzer - CJS Securities, Inc. Jayson Tyler Bedford - Raymond James & Associates, Inc., Research Division Michael Toomey - Jefferies LLC, Research Division Michael Stephen M...
Positive
The Motley Fool
17 days ago
ICU Medical (ICUI 2.40%), a medical device company specializing in infusion therapy and related products, released its second quarter results on August 7, 2025. The most important news from the report was a significant earnings per share (EPS) beat, with adjusted EPS of $2.10 (Non-GAAP) compared to analyst expectations of $1.50, a positive difference of 40.0% (Non-GAAP).
More ICU Medical, Inc. News

Company Profile

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

Head office United States
CEO Vivek Jain
Employees 15,000
Founded 1984
Website www.icumed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today